These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33129098)

  • 1. Recent insights of the role and signalling pathways of interleukin-34 in liver diseases.
    Al-Shaebi F; Wenzhang L; Hezam K; Almezgagi M; Wei L
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107023. PubMed ID: 33129098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.
    Plaza-Diaz J; Gomez-Llorente C; Fontana L; Gil A
    World J Gastroenterol; 2014 Nov; 20(42):15632-49. PubMed ID: 25400447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines.
    Lu DH; Guo XY; Qin SY; Luo W; Huang XL; Chen M; Wang JX; Ma SJ; Yang XW; Jiang HX
    World J Gastroenterol; 2015 Feb; 21(5):1531-45. PubMed ID: 25663772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Interleukin-22 in chronic liver injury.
    Carmo RF; Cavalcanti MSM; Moura P
    Cytokine; 2017 Oct; 98():107-114. PubMed ID: 27816383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of naringenin in liver diseases: Molecular mechanisms.
    Hernández-Aquino E; Muriel P
    World J Gastroenterol; 2018 Apr; 24(16):1679-1707. PubMed ID: 29713125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Interleukin-20 Cytokine Family in Liver Disease.
    Caparrós E; Francés R
    Front Immunol; 2018; 9():1155. PubMed ID: 29892294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6: A promising cytokine to support liver regeneration and adaptive immunity in liver pathologies.
    Naseem S; Hussain T; Manzoor S
    Cytokine Growth Factor Rev; 2018 Feb; 39():36-45. PubMed ID: 29361380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 22 in Liver Injury, Inflammation and Cancer.
    Wu Y; Min J; Ge C; Shu J; Tian D; Yuan Y; Zhou D
    Int J Biol Sci; 2020; 16(13):2405-2413. PubMed ID: 32760208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-22 modulates IL-17A production and controls inflammation and tissue damage in experimental dengue infection.
    Guabiraba R; Besnard AG; Marques RE; Maillet I; Fagundes CT; Conceição TM; Rust NM; Charreau S; Paris I; Lecron JC; Renauld JC; Quesniaux V; Da Poian AT; Arruda LB; Souza DG; Ryffel B; Teixeira MM
    Eur J Immunol; 2013 Jun; 43(6):1529-44. PubMed ID: 23505056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between inflammatory mediators and endoplasmic reticulum stress in liver diseases.
    Duvigneau JC; Luís A; Gorman AM; Samali A; Kaltenecker D; Moriggl R; Kozlov AV
    Cytokine; 2019 Dec; 124():154577. PubMed ID: 30446215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopathobiology and therapeutic targets related to cytokines in liver diseases.
    He Y; Hwang S; Ahmed YA; Feng D; Li N; Ribeiro M; Lafdil F; Kisseleva T; Szabo G; Gao B
    Cell Mol Immunol; 2021 Jan; 18(1):18-37. PubMed ID: 33203939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to modulate inflammatory cytokines in liver diseases.
    Tilg H; Kaser A; Moschen AR
    Liver Int; 2006 Nov; 26(9):1029-39. PubMed ID: 17032402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alkannin Inhibited Hepatic Inflammation in Diabetic Db/Db Mice.
    Xue W; Fan Z; Li Y; Li L; Zhang T; Lu J; Ma B; Zhu Z; Lian J; Zhang C; Song X; Sun D; Zhai Y; Fan R; Cao Y; Deng X; Zhao J
    Cell Physiol Biochem; 2018; 45(6):2461-2470. PubMed ID: 29554661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of inflammation and liver cancer.
    Bishayee A
    Adv Exp Med Biol; 2014; 816():401-35. PubMed ID: 24818732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 32, inflammation and cancer.
    Hong JT; Son DJ; Lee CK; Yoon DY; Lee DH; Park MH
    Pharmacol Ther; 2017 Jun; 174():127-137. PubMed ID: 28223235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 3 innate lymphoid cell: a new player in liver fibrosis progression.
    Wang S; Li J; Wu S; Cheng L; Shen Y; Ma W; She W; Yang C; Wang J; Jiang W
    Clin Sci (Lond); 2018 Dec; 132(24):2565-2582. PubMed ID: 30459204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus induces a novel inflammation network involving three inflammatory factors, IL-29, IL-8, and cyclooxygenase-2.
    Yu Y; Gong R; Mu Y; Chen Y; Zhu C; Sun Z; Chen M; Liu Y; Zhu Y; Wu J
    J Immunol; 2011 Nov; 187(9):4844-60. PubMed ID: 21957142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-19 as an Immunoregulatory Cytokine.
    Fujimoto Y; Kuramoto N; Yoneyama M; Azuma YT
    Curr Mol Pharmacol; 2021; 14(2):191-199. PubMed ID: 32329704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk network among multiple inflammatory mediators in liver fibrosis.
    Zhangdi HJ; Su SB; Wang F; Liang ZY; Yan YD; Qin SY; Jiang HX
    World J Gastroenterol; 2019 Sep; 25(33):4835-4849. PubMed ID: 31543677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.